Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD

Abroad (travel likely)Recruiting

Conditions

Graft vs Host Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Hengwei Wu) · wuhengwei@zju.edu.cn · 0571 87236562